---
title: "Hvsen Biotech: In the first half of this year, it has obtained 7 pet product approvals, greatly expanding its pet product line"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252579906.md"
description: "Hvsen Biotech stated on the investor interaction platform that the pet medicine sector is one of the key development directions of the company. The company is adjusting resource allocation and increasing investment in the research and development of pet medicines and the construction of market channels. It has established an independent and specialized pet medicine R&D team, and in the first half of this year, it has obtained 7 pet product approvals, greatly expanding its pet product line. The company's pet medicines mainly involve sub-sectors such as pet deworming, antipyretic and analgesic medications, dermatological drugs, internal medicine diseases, and functional health products"
datetime: "2025-08-12T01:27:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252579906.md)
  - [en](https://longbridge.com/en/news/252579906.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252579906.md)
---

# Hvsen Biotech: In the first half of this year, it has obtained 7 pet product approvals, greatly expanding its pet product line

Hvsen Biotech stated on the investor interaction platform that the pet medicine sector is one of the company's key development directions. The company is adjusting resource allocation and increasing investment in the research and development of pet medicines and market channel construction. It has established an independent and specialized pet medicine R&D team, and in the first half of this year, it has obtained 7 pet product approvals, greatly expanding its pet product line. The company's pet medicines mainly involve sub-sectors such as pet deworming, antipyretic and analgesic, dermatological medications, internal medicine diseases, and functional health products

### Related Stocks

- [300871.CN](https://longbridge.com/en/quote/300871.CN.md)

## Related News & Research

- [01:00 ET"Greatest Tomatoes from Europe" Returns to the USA to Celebrate the Quality, Heritage, and Versatility of European and Italian Canned Tomatoes](https://longbridge.com/en/news/287007471.md)
- [TECHNICALS-CBOT soybeans may extend gains into $12.13-1/2 to $12.17-1/4 range](https://longbridge.com/en/news/287016093.md)
- [ZAWYA: VIDEO: Dubai-based eyewear firm Magrabi Retail to acquire 51% stake in Egypt’s Baraka Optics](https://longbridge.com/en/news/286881451.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [ZAWYA: GlobalCorp secures Egypt’s largest mortgage securitization at $62mln](https://longbridge.com/en/news/286715027.md)